FOCUS may lower PE diagnosis in ED patients with suspected PE and abnormal vitals

DES PLAINES, IL — Focused cardiac ultrasound (FOCUS) performed by emergency physicians with advanced training in emergency ultrasound may significantly lower the likelihood of the diagnosis of pulmonary embolism (PE) in most patients who are suspected of PE and have…

Wills Eye Hospital presents 4 inaugural awards at gala celebrating renowned retina service

Beloved, late retina surgeon is remembered, his family receives standing ovation as hospital leaders announce early outpouring of support with over 1 million dollars raised for research fund in his name

Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

US Innovation Program brings international entrepreneurs to Purdue

WEST LAFAYETTE, Ind. – The Purdue Research Foundation and the Purdue Foundry entrepreneurial community are helping to host a pair of entrepreneurs from Brazil and Uganda as part of the U.S. Department of State’s Global Innovation through Science and Technology…

Updated Report on Trends in Global PD-1/PD-L1 Immunotherapy Clinical Development from the Cancer Research Institute Published in Nature Reviews Drug Discovery

Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to China.

SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide

The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…

SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide

The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…

SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide

The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…

Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials

November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat “due to a mutational profile that makes it resistant to therapies that work better for other tumor types,” explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.

Researchers find risk factors for unemployment with multiple sclerosis vary by age

Kessler Foundation researchers studied relationships of multiple factors — age, disease, psychological, person-specific — with unemployment in individuals with multiple sclerosis

Influenza human challenge study begins at NIAID-sponsored clinical trial units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH’s National Institute of Allergy and Infectious Diseases (NIAID).…

FMT is effective in IBS, but having a ‘super-donor’ is essential, new study finds

(Barcelona, October 21, 2019) The results of a large, randomised, double-blind, placebo-controlled study have confirmed that faecal microbiota transplantation (FMT) using a single ‘super-donor’ is an effective and well tolerated treatment for irritable bowel syndrome (IBS), producing high rates of…

EPFL is developing next-generation soft hearing implants

Close to half a million people around the world suffer from a serious hearing impairment. In some cases, they can find relief in cochlear and other types of implants. Yet these devices do not help people whose inner ear is…

Listening to ‘noisy knees’ to diagnose osteoarthritis: The first human cohort study

A new way of diagnosing and assessing knee osteoarthritis (OA) has moved a step closer with a major study paving the way for its use in research and clinical practice. The technique involves attaching small microphones to knees, and detecting…

First study to test healthy lifestyle changes in reducing the risk of dementia in a large-scale, diverse population in the United States

A new study at Rush University Medical Center aims to determine whether a combination of lifestyle changes can protect memory and thinking skills in people at risk of developing dementia. The two-year U.S. Study to Protect Brain Health Through Lifestyle…

Hyperfine and Yale School of Medicine collaborate on world’s first portable MRI technology

Guilford, CT, October 14, 2019 — Hyperfine Research Inc. announced today its collaboration with the Yale School of Medicine to pioneer the use of the world’s first portable, low-cost magnetic resonance imaging (MRI) system at the bedside of patients in…

Overcoming the blood-brain-barrier: Delivering therapeutics to the brain

For the first time, scientists have identified a simple way that can effectively transport medication into the brain – which could lead to improved treatments for neurological and neurodegenerative diseases. In a study published today in Nature Communications , scientists…

Type 2 diabetes and obesity could be treated by new, less invasive procedure

New research from King’s College London published in EBioMedicine , has found that a newly tested medical device, called Sleeveballoon, mimics the effects of traditional bariatric surgery in rodents and produces impressive results on body weight, fatty liver and diabetes…